本期重点报道

S. Suetani
{"title":"本期重点报道","authors":"S. Suetani","doi":"10.1192/bjp.2022.186","DOIUrl":null,"url":null,"abstract":"In this issue of BJPsych, the editorial by Goodday et al (pp. 51–53) argues that digital health technologies could potentially redesign the psychiatry field. We base our assessment and treatment on self-reported symptoms in intermittent clinical encounters. What if we could bring more objectivity to our practice? Like Holter monitoring for blood pressure, can we monitor dynamic behaviour, emotion and physiological responses in real time? In the related Analysis, Rocheteau elegantly outlines the issues associated with artificial intelligence in psychiatry. Of note, Rocheteau touches on the idea of online psychotherapy. What if we replace human therapists with ‘robo-therapists’who can recall your story, deep learn and stick to manualised therapy perfectly? We already have the technology to produce speech that is indistinguishable from that of humans. The future may be closer than we think it is. The multicentre randomised control trial by Gnanapragasam et al (pp. 58–66) brings us back to reality. The study examines the effectiveness of the ‘Foundations’ app among UK healthcare workers. The app reduced general psychiatric morbidity and insomnia while improving the mental well-being of the intervention group. The app did not, however, have any significant impact on symptoms of depression or anxiety, or on resilience, presenteeism and functioning. Another paper on COVID in this issue Fancourt et al (pp. 74–81) further examines depressive and anxiety symptoms. Using data from the UCL COVID-19 Social Study, the authors found that compared with the short-COVID group, those with long COVID experienced significantly higher levels of depressive symptoms but comparable levels of anxiety symptoms at the onset of COVID infection. Over the subsequent 22 months, both the depressive and anxiety symptoms for the long-COVID group remained elevated whereas the symptoms were reduced back to the baseline for the short-COVID group. Even in a developed nation like Australia where I practice, pharmacological intervention is vastly more available and affordable (and thus accessible) than psychological intervention. I can only imagine how limited access might be in lowand middle-income countries with a distinct lack of trained professionals. The Healthy Activity Program trial demonstrated that you don’t need fancy degrees to help people. Through the programme, behavioural activation delivered by lay counsellors in Goa, India, significantly improved the remission rate from depression. In this issue, Seward et al (pp. 67–73) further explore the data from the trial to see if they could find specific aspects that improved outcomes. The authors found that the reduction in depressive symptoms was mediated through improved levels of behavioural activation. Surprisingly, they found no mediating effects through factors such as the number of sessions, homework completed, response to therapy or number of additional sessions. Given the findings, the authors suggested that if people are not responding to the behavioural activation, alternative treatment should be offered rather than persisting with additional sessions. Perhaps we can offer ‘robo-therapy’ soon. Finally, Goto et al (pp. 82–87) evaluate the state of Ukrainian in-patient mental health services in April 2022, a couple of months after the war began. Based on interviews with the heads of 32 in-patient mental health facilities in Ukraine, the authors found that the hospital admission rate decreased by nearly a quarter compared with before the war, with much of the reduction coming from the eastern regions occupied by Russia. Despite the decrease in hospital admission, the authors argued that there remain significant unmet mental health needs in Ukraine. One potential solution suggested was seeking the help of non-mental-health specialists (as described in the Healthy Activity Program). Another solution was to strengthen remote mental health support (perhaps an app like ‘Foundations’ may be adapted to fit the Ukrainian setting). I recently re-read Aldous Huxley’s Brave New World for the first time since high school. This issue of BJPsych contains artificial intelligence, robo-therapy, ‘Foundations’, a pandemic, behavioural activation and a war in Europe. Our community feels much smaller yet much more divided. As we seek our identity in this era of confusion and chaos, stability remains a couple of steps away. Reading through this month’s BJPsych, I wondered what Huxley would have made of the brave new world we live in now. The British Journal of Psychiatry (2023) 222, A7. doi: 10.1192/bjp.2022.186","PeriodicalId":22495,"journal":{"name":"The British Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Highlights of this issue\",\"authors\":\"S. Suetani\",\"doi\":\"10.1192/bjp.2022.186\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In this issue of BJPsych, the editorial by Goodday et al (pp. 51–53) argues that digital health technologies could potentially redesign the psychiatry field. We base our assessment and treatment on self-reported symptoms in intermittent clinical encounters. What if we could bring more objectivity to our practice? Like Holter monitoring for blood pressure, can we monitor dynamic behaviour, emotion and physiological responses in real time? In the related Analysis, Rocheteau elegantly outlines the issues associated with artificial intelligence in psychiatry. Of note, Rocheteau touches on the idea of online psychotherapy. What if we replace human therapists with ‘robo-therapists’who can recall your story, deep learn and stick to manualised therapy perfectly? We already have the technology to produce speech that is indistinguishable from that of humans. The future may be closer than we think it is. The multicentre randomised control trial by Gnanapragasam et al (pp. 58–66) brings us back to reality. The study examines the effectiveness of the ‘Foundations’ app among UK healthcare workers. The app reduced general psychiatric morbidity and insomnia while improving the mental well-being of the intervention group. The app did not, however, have any significant impact on symptoms of depression or anxiety, or on resilience, presenteeism and functioning. Another paper on COVID in this issue Fancourt et al (pp. 74–81) further examines depressive and anxiety symptoms. Using data from the UCL COVID-19 Social Study, the authors found that compared with the short-COVID group, those with long COVID experienced significantly higher levels of depressive symptoms but comparable levels of anxiety symptoms at the onset of COVID infection. Over the subsequent 22 months, both the depressive and anxiety symptoms for the long-COVID group remained elevated whereas the symptoms were reduced back to the baseline for the short-COVID group. Even in a developed nation like Australia where I practice, pharmacological intervention is vastly more available and affordable (and thus accessible) than psychological intervention. I can only imagine how limited access might be in lowand middle-income countries with a distinct lack of trained professionals. The Healthy Activity Program trial demonstrated that you don’t need fancy degrees to help people. Through the programme, behavioural activation delivered by lay counsellors in Goa, India, significantly improved the remission rate from depression. In this issue, Seward et al (pp. 67–73) further explore the data from the trial to see if they could find specific aspects that improved outcomes. The authors found that the reduction in depressive symptoms was mediated through improved levels of behavioural activation. Surprisingly, they found no mediating effects through factors such as the number of sessions, homework completed, response to therapy or number of additional sessions. Given the findings, the authors suggested that if people are not responding to the behavioural activation, alternative treatment should be offered rather than persisting with additional sessions. Perhaps we can offer ‘robo-therapy’ soon. Finally, Goto et al (pp. 82–87) evaluate the state of Ukrainian in-patient mental health services in April 2022, a couple of months after the war began. Based on interviews with the heads of 32 in-patient mental health facilities in Ukraine, the authors found that the hospital admission rate decreased by nearly a quarter compared with before the war, with much of the reduction coming from the eastern regions occupied by Russia. Despite the decrease in hospital admission, the authors argued that there remain significant unmet mental health needs in Ukraine. One potential solution suggested was seeking the help of non-mental-health specialists (as described in the Healthy Activity Program). Another solution was to strengthen remote mental health support (perhaps an app like ‘Foundations’ may be adapted to fit the Ukrainian setting). I recently re-read Aldous Huxley’s Brave New World for the first time since high school. This issue of BJPsych contains artificial intelligence, robo-therapy, ‘Foundations’, a pandemic, behavioural activation and a war in Europe. Our community feels much smaller yet much more divided. As we seek our identity in this era of confusion and chaos, stability remains a couple of steps away. Reading through this month’s BJPsych, I wondered what Huxley would have made of the brave new world we live in now. The British Journal of Psychiatry (2023) 222, A7. doi: 10.1192/bjp.2022.186\",\"PeriodicalId\":22495,\"journal\":{\"name\":\"The British Journal of Psychiatry\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The British Journal of Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1192/bjp.2022.186\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The British Journal of Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1192/bjp.2022.186","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

在这一期的《BJPsych》杂志上,Goodday等人的社论(第51-53页)认为,数字健康技术可能会重新设计精神病学领域。我们的评估和治疗基于间歇性临床接触中自我报告的症状。如果我们能让我们的实践更客观呢?就像动态心电图监测血压一样,我们能实时监测动态行为、情绪和生理反应吗?在相关的分析中,罗彻托优雅地概述了与精神病学中的人工智能相关的问题。值得注意的是,罗彻托提到了在线心理治疗的概念。如果我们用“机器人治疗师”取代人类治疗师,他们可以回忆你的故事,深度学习,并完美地坚持手动治疗,那会怎么样?我们已经拥有了制造与人类无法区分的语音的技术。未来可能比我们想象的更近。Gnanapragasam等人的多中心随机对照试验(第58-66页)将我们带回现实。这项研究调查了“基础”应用程序在英国医护人员中的有效性。该应用程序降低了一般精神疾病发病率和失眠,同时改善了干预组的心理健康。然而,这款应用对抑郁或焦虑症状,以及对适应力、出勤和功能没有任何显著影响。本期关于COVID的另一篇论文Fancourt等人(第74-81页)进一步研究了抑郁和焦虑症状。作者利用伦敦大学学院COVID-19社会研究的数据发现,与短COVID组相比,长COVID组在感染COVID时抑郁症状水平明显较高,但焦虑症状水平相当。在随后的22个月里,长covid组的抑郁和焦虑症状仍然升高,而短covid组的症状则降至基线。即使在像澳大利亚这样的发达国家,药物干预也比心理干预更容易获得和负担得起(因此更容易获得)。我只能想象,在明显缺乏训练有素的专业人员的低收入和中等收入国家,获得医疗服务的机会可能会多么有限。健康活动计划的试验表明,你不需要高学历来帮助别人。通过该项目,印度果阿的非专业咨询师提供的行为激活显著提高了抑郁症的缓解率。在这一期中,苏厄德等人(第67-73页)进一步探讨了试验的数据,看看他们是否能找到改善结果的具体方面。作者发现,抑郁症状的减轻是通过行为激活水平的提高来调节的。令人惊讶的是,他们没有发现诸如治疗次数、完成的作业、对治疗的反应或额外治疗次数等因素的中介作用。鉴于这些发现,作者建议,如果人们对行为激活没有反应,应该提供替代治疗,而不是坚持进行额外的治疗。也许我们很快就能提供“机器人疗法”。最后,Goto等人(第82-87页)在战争开始几个月后的2022年4月评估了乌克兰住院精神卫生服务的状况。根据对乌克兰32家住院精神卫生机构负责人的采访,提交人发现,与战前相比,住院率下降了近四分之一,其中大部分下降来自俄罗斯占领的东部地区。尽管住院人数有所减少,但作者认为,乌克兰仍有大量精神卫生需求未得到满足。一个可能的解决方案是寻求非心理健康专家的帮助(如健康活动计划所述)。另一个解决方案是加强远程心理健康支持(或许可以对“Foundations”这样的应用程序进行修改,以适应乌克兰的环境)。自从高中毕业后,我最近第一次重读了阿道斯·赫胥黎的《美丽新世界》。本期BJPsych包含人工智能、机器人治疗、“基础”、流行病、行为激活和欧洲战争。我们的社区感觉更小了,也更分裂了。当我们在这个混乱和混乱的时代寻求我们的身份认同时,稳定离我们还有几步之遥。读完这个月的BJPsych,我想知道赫胥黎会如何看待我们现在生活的美丽新世界。英国精神病学杂志(2023)222,A7。doi: 10.1192 / bjp.2022.186
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Highlights of this issue
In this issue of BJPsych, the editorial by Goodday et al (pp. 51–53) argues that digital health technologies could potentially redesign the psychiatry field. We base our assessment and treatment on self-reported symptoms in intermittent clinical encounters. What if we could bring more objectivity to our practice? Like Holter monitoring for blood pressure, can we monitor dynamic behaviour, emotion and physiological responses in real time? In the related Analysis, Rocheteau elegantly outlines the issues associated with artificial intelligence in psychiatry. Of note, Rocheteau touches on the idea of online psychotherapy. What if we replace human therapists with ‘robo-therapists’who can recall your story, deep learn and stick to manualised therapy perfectly? We already have the technology to produce speech that is indistinguishable from that of humans. The future may be closer than we think it is. The multicentre randomised control trial by Gnanapragasam et al (pp. 58–66) brings us back to reality. The study examines the effectiveness of the ‘Foundations’ app among UK healthcare workers. The app reduced general psychiatric morbidity and insomnia while improving the mental well-being of the intervention group. The app did not, however, have any significant impact on symptoms of depression or anxiety, or on resilience, presenteeism and functioning. Another paper on COVID in this issue Fancourt et al (pp. 74–81) further examines depressive and anxiety symptoms. Using data from the UCL COVID-19 Social Study, the authors found that compared with the short-COVID group, those with long COVID experienced significantly higher levels of depressive symptoms but comparable levels of anxiety symptoms at the onset of COVID infection. Over the subsequent 22 months, both the depressive and anxiety symptoms for the long-COVID group remained elevated whereas the symptoms were reduced back to the baseline for the short-COVID group. Even in a developed nation like Australia where I practice, pharmacological intervention is vastly more available and affordable (and thus accessible) than psychological intervention. I can only imagine how limited access might be in lowand middle-income countries with a distinct lack of trained professionals. The Healthy Activity Program trial demonstrated that you don’t need fancy degrees to help people. Through the programme, behavioural activation delivered by lay counsellors in Goa, India, significantly improved the remission rate from depression. In this issue, Seward et al (pp. 67–73) further explore the data from the trial to see if they could find specific aspects that improved outcomes. The authors found that the reduction in depressive symptoms was mediated through improved levels of behavioural activation. Surprisingly, they found no mediating effects through factors such as the number of sessions, homework completed, response to therapy or number of additional sessions. Given the findings, the authors suggested that if people are not responding to the behavioural activation, alternative treatment should be offered rather than persisting with additional sessions. Perhaps we can offer ‘robo-therapy’ soon. Finally, Goto et al (pp. 82–87) evaluate the state of Ukrainian in-patient mental health services in April 2022, a couple of months after the war began. Based on interviews with the heads of 32 in-patient mental health facilities in Ukraine, the authors found that the hospital admission rate decreased by nearly a quarter compared with before the war, with much of the reduction coming from the eastern regions occupied by Russia. Despite the decrease in hospital admission, the authors argued that there remain significant unmet mental health needs in Ukraine. One potential solution suggested was seeking the help of non-mental-health specialists (as described in the Healthy Activity Program). Another solution was to strengthen remote mental health support (perhaps an app like ‘Foundations’ may be adapted to fit the Ukrainian setting). I recently re-read Aldous Huxley’s Brave New World for the first time since high school. This issue of BJPsych contains artificial intelligence, robo-therapy, ‘Foundations’, a pandemic, behavioural activation and a war in Europe. Our community feels much smaller yet much more divided. As we seek our identity in this era of confusion and chaos, stability remains a couple of steps away. Reading through this month’s BJPsych, I wondered what Huxley would have made of the brave new world we live in now. The British Journal of Psychiatry (2023) 222, A7. doi: 10.1192/bjp.2022.186
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Racial disparities influence access and outcomes in talking therapies Taming the Chimaera–Hydra: disconnecting from the net to fortify our mental health Artificial intelligence and cybercrime: implications for individuals and the healthcare sector Chronopsychiatry Racism in psychiatry and the case of presentism
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1